Expert Views from Pharma and Biotech Industry Leaders
Refine Search
Biotechnology
An Expert View providing best practices on developing a sound commercial strategy, building out secure logistics platforms, and creating a connected ecosystem through technology from Andrea Zobel, senior director of Personalized Supply Chain at World Courier (a part of AmerisourceBergen), Melissa Lattanzi, senior director of Channel Strategy at AmerisourceBergen, and Jason Ramseth, chief product officer at TrakCel. 14 February 2022
Pharmaceutical
Steve Kent, chairman at Pharmaspectra, a data business with a focus on medical affairs, provides an Expert View on the increasing impact of data in medicine. 27 January 2022
Pharmaceutical
Stephen Page, founder and chief executive of Page & Page, provides an Expert View on the need for bolder communications in 2022. 14 January 2022
Pharmaceutical
Adrian Tombling, partner and life sciences sector specialist at European intellectual property firm, Withers & Rogers, offers an Expert View on why patents are not the real barrier and why we need them to guard the human race against the risks posed by COVID-19 mutations or future pandemics. 4 January 2022
Pharmaceutical
Real world evidence (RWE) continues to grow as a promising frontier in evidence generation to support positive health outcomes. It can be useful in evaluating unmet healthcare needs, real world standard of care, and patient-reported outcomes, as well as developing realistic trial designs and budget impact models. 13 December 2021
Pharmaceutical
An Expert View on the importance of embedding a modern quality culture from David Fryrear, executive vice president and head of quality assurance, Medical and Development, Astellas Pharma Global Development. 9 December 2021
Pharmaceutical
Vicki Pearson, global solutions architect, life sciences at Schneider Electric, provides an Expert View on how firms can meet a growing demand while remaining affordable and accessible. 30 November 2021
Pharmaceutical
Ester Banque, senior vice president and head of intercontinental commercial at Bristol Myers Squibb, provides an Expert View on coping with 'The Great Resignation'. 12 November 2021
Pharmaceutical
The National Institute for Health and Care Excellence's (NICE) consultation on the proposed changes to its methods and processes of health technology assessment closed on October 13. Here Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at NICE, provides an Expert View on the proposed fresh approach to health technology assessment and how this will allow continued fair and fast access to medicines in the National Health Service (NHS). 5 November 2021
Pharmaceutical
Paul Domenet, partner and communications creative director at Free The Birds, offers an Expert View on how big pharma can improve its image. 26 October 2021
Pharmaceutical
The news cycle has hit overdrive in the UK ahead of a frenetic couple of weeks that include the Autumn Budget, a Comprehensive Spending Review and the COP26 conference in Glasgow. 26 October 2021
Pharmaceutical
An Expert View from Gary Connors, partner at Oliver Wight, on intellectual property rights protection and drug development. 15 October 2021
Pharmaceutical
Carima Andrady, senior regulatory writer at PharmaLex, provides an Expert View on a key consideration when seeking to secure an Orphan Drug designation (ODD) in Europe. 8 October 2021
Pharmaceutical
Uwe Trinks, global practice lead for pharmacovigilance technologies, IQVIA, provides an Expert View on how the pharmaceutical industry can make a success of new working practices. 21 September 2021
Biotechnology
Kees Melief, chief scientific officer of ISA Pharmaceuticals, provides an Expert View on why therapeutic cancer vaccines will be a success following many years of being out of favor. 3 September 2021
Pharmaceutical
Eva Marchese, Abhishek Kumar and Kees Chamberlain from Charles River Associates examine how the COVID-19 pandemic is expected to impact payers’ management of pharmaceutical budgets in Europe in an Expert View column. 26 August 2021
Pharmaceutical
Raman Sehgal, the founder of ramarketing, provides an Expert View on how pharmaceutical and life sciences businesses can market themselves in the post-pandemic environment. 10 August 2021
Pharmaceutical
Luke Robinson, relationship manager at Included, tackles an important issue for the sector in an Expert View piece. 3 August 2021
Pharmaceutical
An Expert View on the pros and cons of intellectual property (IP) protections in the pharmaceutical sector from White & Case partners' competition lawyer, James Killick, chair of the firm’s IP practice, Anita Varma, and associate and member of the Global Competition practice group, Alexander Krois. 20 July 2021
Pharmaceutical
Merlin Piscitelli, chief revenue officer for EMEA at Datasite, provides an Expert View on M&A trends and predictions for deal-making in life sciences, and some of the challenges we may expect. 1 July 2021
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
As stakeholders in the pharmaceutical industry, we all have a responsibility to ensure life-saving treatments promptly and safely reach patients regardless of where they live. To this end, by integrating early access programs and other less conventional strategies into a company’s business model for drug distribution, patients who are suffering from life-threatening conditions can gain access to needed treatments in regions where there is a lack of drug accessibility, while at the same time offering benefits to pharmaceutical companies. 2 October 2024
Pharmaceutical
An Expert View from Leslie Orne, president and chief executive, Trinity Life Sciences. 20 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
An Expert View from the new chief executive of Gavi, the Vaccine Alliance, Sania Nishtar. 13 August 2024
Pharmaceutical
The biopharmaceutical supply chain plays a pivotal role in ensuring the seamless delivery of therapeutics to patients. However, pharmaceutical supply chains face several challenges, including regulatory complexities, global competition, and the need for innovation. 26 July 2024
Pharmaceutical
An Expert View from William Hind of Alpharmaxim and Lisa Campbell of SSI Strategy. 18 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Biotechnology
An Expert View from Danie du Plessis, executive vice president, pharmaceutical operations at Kyowa Kirin International, and chair of the Medical Affairs Professional Society (MAPS) board. 29 May 2024
Pharmaceutical
The use of AI across all industries and sectors has been heralded as driving efficiency and accelerating innovation, with some experts even citing the technology as the biggest disruptor of our lifetime. 21 May 2024
Expert View
In an Expert View column, Bruce Leuchter, chief executive of Neurvati Neurosciences, a Blackstone Life Sciences portfolio company, outlines the importance of increased investment in research and development and innovative business models, to bring more therapies for neurological disorders to patients. 17 May 2024
Biotechnology
A new age of innovation in immunology could change medical practice and people’s lives, as long as all parts of the system learn, evolve and work together, writes Anant Murthy, General Manager, argenx EMEA, in an Expert View piece. 1 May 2024
Pharmaceutical
An Expert View from Adrienne Rivlin, a partner in LEK’s Healthcare practice. 19 April 2024
Pharmaceutical
A second Expert View piece from Xandra Neuberger, associate director, regulatory affairs and international service lead for clinical trial applications at PharmaLex. 4 April 2024
Biotechnology
An Expert View from Tomislav Kamenski, Senior Director, Therapy Area Market Access Leader, Hematology, Johnson & Johnson. 25 March 2024
Pharmaceutical
An Expert View from Rajan Jethwa, chief executive of Ellipses Pharma. 24 March 2024
Pharmaceutical
Xandra Neuberger, associate director, regulatory affairs and international service lead for clinical trial applications at PharmaLex, provides an Expert View. 29 February 2024
Pharmaceutical
In an Expert View piece, Mark Seymour, Director and Head of Media, Healthcare, at FleishmanHillard London, argues that in the ever-evolving world of healthcare, the rules of communications have not changed, they have just become more intricate, demanding a renewed focus on the essentials. 8 February 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze